Pediatrics Articles
Pediatrics
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Pediatrics
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Pediatrics
        Adolescent Medicine
        Basic Science/Genetics
        Child/Adolescent Psych
        Clinical Pharmacology
        Developmental Peds
        Economics of Medicine
        Epidemiology
        Neonatology
        Nephrology/Urology
        Pathology
        Pediatric Cardiology
        Pediatric Dermatology
        Pediatric Emergencies
        Pediatric Endocrinology
        Pediatric Heme/Oncology
        Pediatric Neurology
        Pediatric Ophthalmology
        Pediatric Ortho/Rheum
        Pediatric Otolaryngology
        Pediatric Pulmonology
        Pediatric Radiology
        Pediatric Surgery
        Peds Allergy/Immunology
        Peds Anesth/Crit Care
        Peds Gastroenterology
        Peds Infectious Disease
        Popular Press
        Preventive/Nutrition
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
gynecomastia  gynecomastia
empyema  empyema
henoch–schönlein  henoch–schönlein
otitis media  otitis media
dyspnea  dyspnea
jaundice  jaundice
ventricle  ventricle
lyme  lyme
immunodeficiency  immunodeficiency
cooling  cooling
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
Inactive disease in polyarticular juvenile idiopathic arthritis: Current patterns and associations
Ringold S et al. – Study reports that children with polyarticular juvenile idiopathic arthritis (JIA) spent the majority of their follow-up with active disease; improving outcomes for these subgroups may be an important goal for prospective study.

Methods
  • Study was undertaken to:
    • Describe the achievement of inactive disease (ID) and remission in JIA and
    • Measure the associations among patient characteristics, imaging results and these outcomes
  • Cohort study of children (n=104) with polyarticular JIA diagnosed and treated between Jan 2000 and Dec 2006
  • Each pt's disease status (active disease vs ID) was determined for every clinic visit
  • Adjusted relative risk estimates were obtained using Mantel–Haenszel methods
Results
  • Pts were followed up for an average of 30 mo
  • Pts achieved 138 episodes of ID; 51 pts achieved 69 episodes of clinical remission on medication
  • When duration of active disease was summed over each pt's f/u, pts spent a mean of 66.3% of their f/u with active disease
  • Pts with evidence of joint damage on imaging studies obtained within 6 mo of their first clinic visit spent a mean of 79% of their f/u with active disease
  • Pts w/o these findings spent a mean of 58.5% of their f/u with active disease
  • Children who were RF+ and children with early evidence of joint damage had higher prevalence of active disease during the f/u
[more...]
Sponsor

Read a Different Specialty

General Pediatrics Journals
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

General Pediatrics Journal Profession Index

General Pediatrics Journals
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.